Case report: Possible links between sickle cell crisis and pentavalent antimony

American Journal of Tropical Medicine and Hygiene

Volumn 86, Issue 6, 2012, Pages 1057-1061

  Garcerant, Daniel ^a,b,c   Rubiano, Luisa ^a,b,c   Blanco, Victor ^a,b,c   Martinez, Javier ^a,b,c   Baker, Nancy C ^b,c,d   Craft, Noah ^b,c,d  

^a CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MÉDICAS CIDEIM   (Colombia)

^b UNC Hamner Institute for Drug Safety Sciences   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMONY; CEFTRIAXONE; FOLIC ACID; GLUTATHIONE; HEMOGLOBIN; MEGLUMINE ANTIMONATE; MILTEFOSINE; MEGLUMINE; MEGLUMINE ANTIMONIATE; ORGANOMETALLIC COMPOUND;

ABDOMINAL PAIN; ARTICLE; CASE REPORT; CHILD; DATA BASE; DIARRHEA; DISEASE ASSOCIATION; GASTROENTERITIS; HUMAN; HYPOTHESIS; MALE; MEDICAL DOCUMENTATION; PRESCHOOL CHILD; PROTEIN INTERACTION; SICKLE CELL ANEMIA; SICKLE CELL CRISIS; SKIN LEISHMANIASIS; SPLENOMEGALY; CHEMICALLY INDUCED DISORDER; LEISHMANIASIS; METABOLISM;

ANEMIA, SICKLE CELL; ANTIMONY; CHILD; GLUTATHIONE; HUMANS; LEISHMANIASIS; MALE; MEGLUMINE; ORGANOMETALLIC COMPOUNDS;

EID: 84862167602     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2012.11-0683     Document Type: Article

References (25)

1. Saravia NG, Weigle K, Navas C, Segura I, Valderrama L, Valencia AZ, Escorcia B, McMahon-Pratt D, 2002. Heterogeneity, geographic distribution, and pathogenicity of serodemes of Leishmania viannia in Colombia. Am J Trop Med Hyg 66: 738-744. (Pubitemid 35001047)
2. Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S, 2007. Cutaneous leishmaniasis. Lancet Infect Dis 7: 581-596. (Pubitemid 47277438)
3. Ballas SK, 2002. Sickle cell anaemia: progress in pathogenesis and treatment. Drugs 62: 1143-1172. (Pubitemid 34587570)
4. Jaramillo M, Sáenz I, Pereira F, 1997. Tamizaje para anemia de células falciformes en recién nacidos del Hospital Universitario del Valle y del Hospital Mario Correa Renjifo. Actual Pediatr (Granada) 7: 3-13.
5. Baker NC, Hemminger BM, 2010. Mining connections between chemicals, proteins, and diseases extracted from Medline annotations. J Biomed Inform 43: 510-519.
6. Hebbel RP, Eaton JW, Balasingam M, Steinberg MH, 1982. Spontaneous oxygen radical generation by sickle erythrocytes. J Clin Invest 70: 1253-1259. (Pubitemid 13168006)
7. Morris CR, Suh JH, Hagar W, Larkin S, Bland DA, Steinberg MH, Vichinsky EP, Shigenaga M, Ames B, Kuypers FA, Klings ES, 2008. Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease. Blood 111: 402-410.
8. Manfredini V, Lazzaretti LL, Griebeler IH, Santin AP, Brandao VD, Wagner S, Castro SM, Peralba MC, Benfato MS, 2008. Blood antioxidant parameters in sickle cell anemia patients in steady state. J Natl Med Assoc 100: 897-902.
9. Reid M, Badaloo A, Forrester T, Jahoor F, 2006. In vivo rates of erythrocyte glutathione synthesis in adults with sickle cell disease. Am J Physiol Endocrinol Metab 291: E73-E79. (Pubitemid 44035311)
10. Somjee SS, Warrier RP, Thomson JL, Ory-Ascani J, Hempe JM, 2005. Advanced glycation end-products in sickle cell anaemia. Br J Haematol 128: 112-118.
11. Li SD, Su YD, Li M, Zou CG, 2006. Hemin-mediated hemolysis in erythrocytes: effects of ascorbic acid and glutathione. Acta Biochim Biophys Sin (Shanghai) 38: 63-69. (Pubitemid 43357046)
12. Dumaswala UJ, Zhuo L, Mahajan S, Nair PN, Shertzer HG, Dibello P, Jacobsen DW, 2001. Glutathione protects chemokine-scavenging and antioxidative defense functions in human RBCs. Am J Physiol Cell Physiol 280: C867-C873.
13. Niihara Y, Matsui NM, Shen YM, Akiyama DA, Johnson CS, Sunga MA, Magpayo J, Embury SH, Kalra VK, Cho SH, Tanaka KR, 2005. L-glutamine therapy reduces endothelial adhesion of sickle red blood cells to human umbilical vein endothelial cells. BMC Blood Disord 5: 4.
14. Cunningham ML, Fairlamb AH, 1995. Trypanothione reductase from Leishmania donovani. Purification, characterization and inhibition by trivalent antimonials. Eur J Biochem 230: 460-468.
15. Wyllie S, Cunningham ML, Fairlamb AH, 2004. Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani. J Biol Chem 279: 39925-39932. (Pubitemid 39258265)
16. Wyllie S, Fairlamb AH, 2006. Differential toxicity of antimonial compounds and their effects on glutathione homeostasis in a human leukemia monocyte cell line. Biochem Pharmacol 71: 257-267. (Pubitemid 41817286)
17. Swanson DR, 1988. Migraine and magnesium: eleven neglected connections. Perspect Biol Med 31: 526-557.
18. Frijters R, van Vugt M, Smeets R, van Schaik R, de Vlieg J, Alkema W, 2010. Literature mining for the discovery of hidden connections between drugs, genes and diseases. PLoS Comput Biol 6: pii: e1000943.
19. Weeber M, Vos R, Klein H, De Jong-Van Den Berg LT, Aronson AR, Molema G, 2003. Generating hypotheses by discovering implicit associations in the literature: a case report of a search for new potential therapeutic uses for thalidomide. J Am Med Inform Assoc 10: 252-259. (Pubitemid 36554786)
20. Hettne KM, Weeber M, Laine ML, ten Cate H, Boyer S, Kors JA, Loos BG, 2007. Automatic mining of the literature to generate new hypotheses for the possible link between periodontitis and atherosclerosis: lipopolysaccharide as a case study. J Clin Periodontol 34: 1016-1024.
21. Kuhn M, von Mering C, Campillos M, Jensen LJ, Bork P, 2008. STITCH: interaction networks of chemicals and proteins. Nucleic Acids Res 36: D684-D688. (Pubitemid 351149807)
22. Baral C, Gonzalez G, Gitter A, Teegarden C, Zeigler A, Joshi-Topé G, 2007. CBioC: beyond a prototype for collaborative annotation of molecular interactions from the literature. Comput Syst Bioinformatics Conf 6: 381-384.
23. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M, 2004. The KEGG resource for deciphering the genome. Nucleic Acids Res 32: D277-D280. (Pubitemid 38081656)
24. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS, 2011. DrugBank 3.0: a comprehensive resource for "omics"research on drugs. Nucleic Acids Res 39: D1035-D1041.
25. Davis AP, King BL, Mockus S, Murphy CG, Saraceni-Richards C, Rosenstein M, Wiegers T, Mattingly CJ, 2011. The Comparative Toxicogenomics Database: update 2011. Nucleic Acids Res 39: D1067-D1072.